Skip to Main Content
Table 1

Risk of Death or Prolonged Length of Stay (LOS) Is Significantly Increased for Patients With Peak or Earliest von Willebrand Factor Antigen (vWF:Ag) >300%a

Risk of Death or Prolonged Length of Stay (LOS) Is Significantly Increased for Patients With Peak or Earliest von Willebrand Factor Antigen (vWF:Ag) >300%a
Risk of Death or Prolonged Length of Stay (LOS) Is Significantly Increased for Patients With Peak or Earliest von Willebrand Factor Antigen (vWF:Ag) >300%a
Close Modal

or Create an Account

Close Modal
Close Modal